Related Experiment Video

Updated: Jul 5, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Cardiometabolic disease in human immunodeficiency virus-infected children

Tracie L Miller1, Yoran T Grant, Daniela Neri Almeida

  • 1Division of Pediatric Clinical Research, Department of Pediatrics, Miller School of Medicine, University of Miami, Miami, FL, USA. tracie.miller@miami.edu

Journal of the Cardiometabolic Syndrome
|May 6, 2008
PubMed

Insights

Children with human immunodeficiency virus (HIV) infection face significant cardiometabolic risks, including lipid issues and insulin resistance. Early monitoring and intervention are crucial for preventing future cardiovascular problems in these young patients.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Cardiology

Background:

  • Cardiometabolic problems are emerging clinical issues in children with human immunodeficiency virus (HIV) infection.
  • These issues include unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness.
  • Phenotypic features like truncal adiposity and wasting are also observed.

Purpose of the Study:

  • To highlight the emerging cardiometabolic challenges in HIV-infected children.
  • To emphasize the need for monitoring and intervention in this population.
  • To underscore the unique exposure of children to both HIV and antiretroviral therapies prenatally.

Main Methods:

  • The abstract does not specify methods but discusses observed clinical problems and risk factors.
  • It implies surveillance of nutrition, body composition, and cardiovascular health markers.
  • It reviews the known cardiometabolic issues in HIV-infected children.

Main Results:

  • HIV-infected children exhibit high rates of adverse lipid profiles and insulin resistance.
  • Cardiovascular inflammation and vascular stiffness are prevalent.
  • Truncal adiposity and facial/extremity wasting are common phenotypic features.

Conclusions:

  • Adverse cardiovascular outcomes risk is poorly defined but warrants close tracking due to early childhood risk factors.
  • Preventive care, including nutrition surveillance, counseling, exercise, and drug therapy, should be standard for HIV-infected children.
  • Early and continuous management is essential for mitigating long-term cardiometabolic complications.

More Related Videos

Isolation, Transfection, and Culture of Primary Human Monocytes09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...